Your Current Location : Fund Card : Portfolio Classification |
|
|
|
ICICI Pru Nifty Pharma Index Fund IDCW Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-1.50 |
Equity |
100.36 |
Trep |
1.14 |
|
|
Concentration Analysis |
Top 5 Holdings |
61.82% |
Top 10 Holdings |
80.67% |
Top 25 Holdings |
100.00% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
100.36 |
Cash |
-0.36 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.86 |
PE Ratio |
38.86 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
25.18 |
Cipla Limited |
10.76 |
Dr Reddys Laboratories Limited |
9.80 |
DIVI LABORATORIES LTD |
9.43 |
Lupin Limited |
6.65 |
Aurobindo Pharma Limited |
4.92 |
Alkem Laboratories Limited |
3.81 |
Torrent Pharmaceuticals Limited |
3.73 |
Glenmark Pharmaceuticals Limited |
3.22 |
Mankind Pharma Limited |
3.17 |
Zydus Lifesciences Limited |
3.16 |
IPCA Laboratories Limited |
2.72 |
Laurus Labs Limited |
2.44 |
Abbott India Limited |
1.90 |
Biocon Limited |
1.79 |
J B Chemicals and Pharma Ltd |
1.76 |
Gland Pharma Limited |
1.65 |
Ajanta Pharma Limited |
1.63 |
Natco Pharma Limited |
1.60 |
TREPS |
1.14 |
Granules India Limited |
1.04 |
Net Current Assets |
-1.50 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|